Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI

ConclusionLow ‐dose MTX/VNL for a defined duration has high efficacy with sustained benefit and minimal toxicity for treating DF.Vtumor and T2 signal might better predict treatment response than RECIST.

Source: Cancer Medicine - July 12, 2019 Category: Cancer & Oncology Authors: Katrina M. Ingley, Sally M. Burtenshaw, Nicole C. Theobalds, Lawrence M. White, Martin E. Blackstein, Rebecca A. Gladdy, Seng Thipphavong, Abha A. Gupta Tags: ORIGINAL RESEARCH Source Type: research